An investigation of the bactericidal activity of chlorhexidine digluconate against multidrug-resistant hospital isolates

被引:9
|
作者
Ekizoglu, Melike [1 ]
Sagiroglu, Meral [1 ]
Kilic, Ekrem [1 ]
Hascelik, Ayse Gulsen [2 ]
机构
[1] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Microbiol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Med Microbiol, TR-06100 Ankara, Turkey
关键词
Biocides; resistance; chlorhexidine digluconate; quantitative suspension test; EN; 1040; STAPHYLOCOCCUS-AUREUS; REDUCED SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; ANTISEPTICS; DISINFECTANTS; BIOCIDES; EFFICACY;
D O I
10.3906/sag-1503-140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: Hospital infections are among the most prominent medical problems around the world. Using proper biocides in an appropriate way is critically important in overcoming this problem. Several reports have suggested that microorganisms may develop resistance or reduce their susceptibility to biocides, similar to the case with antibiotics. In this study we aimed to determine the antimicrobial activity of chlorhexidine digluconate against clinical isolates. Materials and methods: The susceptibility of 120 hospital isolated strains of 7 bacterial genera against chlorhexidine digluconate was determined by agar dilution test, using minimum inhibitory concentration (MIC) values and the EN 1040 Basic Bactericidal Activity Test to determine the bactericidal activity. According to MIC values, Pseudomonas aeruginosa and Stenotrophomonas maltophilia were found to be less susceptible to chlorhexidine digluconate. Results: Quantitative suspension test results showed that 4% chlorhexidine digluconate was effective against antibiotic resistant and susceptible bacteria after 5 min of contact time and can be safely used in our hospital. However, concentrations below 4% chlorhexidine digluconate caused a decrease in bactericidal activity, especially for Staphylococcus aureus and P. aeruginosa. Conclusion: It is crucial to use biocides at appropriate concentrations and to perform surveillance studies to trace resistance or low susceptibility patterns of S. aureus, P. aeruginosa, and other hospital isolates.
引用
收藏
页码:903 / 909
页数:7
相关论文
共 50 条
  • [21] In Vitro Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) Staphylococcus aureus Isolates
    Bongiorno, Dafne
    Lazzaro, Lorenzo Mattia
    Stefani, Stefania
    Campanile, Floriana
    ANTIBIOTICS-BASEL, 2020, 9 (12): : 1 - 8
  • [22] In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus
    Narayanaswamy, Vidya P.
    Giatpaiboon, Scott A.
    Uhrig, John
    Orwin, Paul
    Wiesmann, William
    Baker, Shenda M.
    Townsend, Stacy M.
    PLOS ONE, 2018, 13 (01):
  • [23] In Vitro Activity of Cefiderocol Against Multidrug-Resistant Gram-Negative Clinical Isolates
    Boyd, Sandra
    Anderson, Karen
    Karlsson, J. Kamile Rasheed Maria
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S291 - S292
  • [24] Synergistic Activity of Indolicidin and Tigecycline Against Multidrug-Resistant Acinetobacter Baumannii Clinical Isolates
    Altameemi, Rami
    Ghareeb, Abdulameer M.
    Rahal, Basim Shamkhi
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2025, 59 (01)
  • [25] Investigation of the Virulence Factors of Multidrug-Resistant Acinetobacter baumannii Isolates
    Erac, Bayri
    Yilmaz, Fethiye Ferda
    Hosgor Limoncu, Mine
    Ozturk, Ismail
    Aydemir, Sohret
    MIKROBIYOLOJI BULTENI, 2014, 48 (01): : 70 - 81
  • [26] Fosfomycin: In vitro efficacy against multidrug-resistant isolates beyond urinary isolates
    Demir, Tulin
    Buyukguclu, Tuncay
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 8 : 164 - 168
  • [27] Investigation of the Antagonistic Activity of Enterococci and Lactobacilli Against Multidrug-resistant Klebsiella Pneumoniae
    Karaseva, Alena
    Ermolenko, Elena
    Lazareva, Irina
    Tsa-Pieva, Anna
    Guo, Danyang
    Sidorenko, Sergey
    Suvorov, Alexander
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2020, 54 : S28 - S28
  • [28] Bactericidal activity of Myrrh extracts and two dosage forms against standard bacterial strains and multidrug-resistant clinical isolates with GC/MS profiling
    Khalil, Noha
    Fikry, Sahar
    Salama, Osama
    AMB EXPRESS, 2020, 10 (01)
  • [29] Bactericidal activity of Myrrh extracts and two dosage forms against standard bacterial strains and multidrug-resistant clinical isolates with GC/MS profiling
    Noha Khalil
    Sahar Fikry
    Osama Salama
    AMB Express, 10
  • [30] PZ-601 antibiotic and bactericidal activity against multidrug-resistant Gram-positive bacteria
    Pace, J.
    Xerri, L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S473 - S473